News

4 readers

1 users here now

Breaking news and current events worldwide.

founded 1 year ago

A Decongestant in Cold Medicines Doesn’t Work at All, an F.D.A. Panel Says. The panel’s vote tees up a likely decision by the agency on whether to essentially ban the ingredient, phenylephrine. (www.nytimes.com)

submitted 1 year ago* (last edited 1 year ago) by btaf45@kbin.social to c/news@kbin.social

12 comments fedilink hide all child comments

The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold or perhaps give companies lead time to substitute other ingredients.

you are viewing a single comment's thread
view the rest of the comments

[–] athos77@kbin.social 3 points 1 year ago* (last edited 1 year ago) (2 children)

Does anyone know if phenylephrine is otherwise harmless? If it's essentially harmless, and assuming all these various products have other ingredients that remain effective, then it seems to me that the easiest thing for the companies to do is to move phenylephrine from the "active ingredients" section to the "inactive ingredients" section.

[–] Chetzemoka@kbin.social 3 points 1 year ago

Oh no, phenylephrine definitely has effects. It's just that decongestion isn't one of them. Intravenous phenylephrine is sometimes used in critical care hospital settings to deliberately raise a person's blood pressure:

https://www.lhsc.on.ca/critical-care-trauma-centre/phenylephrine-neosynephrine

[–] girl@lemmy.best 2 points 1 year ago* (last edited 1 year ago)

It is harmless. But moving it to the inactive ingredients will still leave many of them without a decongestant and they’ll have to change all of their packaging/marketing. The other ingredients are usually for fever reduction or cough suppression. It would be a waste of their money to keep a useless ingredient.